Background: Gauging fitness remains a challenge among older adults with hematologic malignancies, and interventions to restore function are lacking. We pilot a structured exercise intervention and novel biologic correlates of aging using epigenetic clocks and markers of immunosenescence to evaluate changes in function and clinical outcomes. Methods: Older adults (n=30) with hematologic malignancy actively receiving treatment were screened and enrolled in a 6-month exercise intervention, the Otago Exercise Programme (OEP). The impact of the OEP on geriatric assessment metrics and health-related quality of life were captured. Clinical outcomes of overall survival and hospital utilization (inpatient length of stay and emergency department use) in relationship to geriatric deficits were analyzed. Results: Older adults (median age, 75.5 years [range, 62–83 years]) actively receiving treatment were enrolled in the OEP. Instrumental activities of daily living and physical health scores (PHS) increased significantly with the OEP intervention (median PHS: visit 1, 55 [range, 0–100]; visit 2, 70 [range, 30–100]; P<.01). Patient-reported Karnofsky performance status increased significantly, and the improvement was sustained (median [range]: visit 1, 80 [40–100]; visit 3, 90 [50–100]; P=.05). Quality of life (Patient-Reported Outcome Measurement Information System [PROMIS]) improved significantly by the end of the 6-month period (median [range]: visit 1, 32.4 [19.9–47.7]; visit 3, 36.2 [19.9–47.7]; P=.01]. Enhanced measures of gait speed and balance, using the Short Physical Performance Battery scores, were associated with a 20% decrease in risk of death (hazard ratio, 0.80; 95% CI, 0.65–0.97; P=.03) and a shorter hospital length of stay (decrease of 1.29 days; 95% CI, −2.46 to −0.13; P=.03). Peripheral blood immunosenescent markers were analyzed in relationship to clinical frailty and reports of mPhenoAge epigenetic analysis are preliminarily reported. Chronologic age had no relationship to overall survival, length of stay, or emergency department utilization. Conclusions: The OEP was effective in improving quality of life, and geriatric tools predicted survival and hospital utilization among older adults with hematologic malignancies.
Submitted June 3, 2020; final revision received November 13, 2020; accepted for publication November 13, 2020.
Published online March 26, 2021.
Author contributions:Study design: Rosko, Sucheston-Campbell, Huang, Burd, Naughton. Patient enrollment: Rosko, Wall, Baiocchi, Benson, Brammer, Byrd, Efebera, Maddocks, Rogers. Research and data analysis: Rosko, Sucheston-Campbell, Tang, Ozer, Huang, Burd. Manuscript preparation: All authors.
Disclosures: Dr. Rosko has reported receiving grant/research support from Janssen, Millennium, and Regeneron. Dr. Rogers has reported receiving grant/research support from Genentech, AbbVie, and Janssen; serving on advisory boards for Acerta Pharma, AstraZeneca, and Pharmacyclics; and receiving travel funds from AztraZeneca. The remaining authors have disclosed that they have not received any financial consideration from any person or organization to support the preparation, analysis, results, or discussion of this article.
Funding: Research reported in this publication was supported by the NCI of the NIH under award number UG1CA189823 Alliance for Clinical Trials in Oncology NCORP Research Base, K23 CA208010-01, and UG1CA233331.
Disclaimer: The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.
Correspondence: Ashley E. Rosko, MD, Division of Hematology, The Ohio State University, A345 Starling Loving Hall, 320 West 10th Avenue, Columbus, OH 43210. Email: Ashley.Rosko@osumc.edu
SoubeyranP, FonckM, Blanc-BissonC, Predictors of early death risk in older patients treated with first-line chemotherapy for cancer. J Clin Oncol 2012;30:1829–1834.10.1200/JCO.2011.35.744222508806)| false
PahorM, GuralnikJM, AmbrosiusWT, et al.Effect of structured physical activity on prevention of major mobility disability in older adults: the LIFE study randomized clinical trial. JAMA2014;311:2387–2396.
PahorM, GuralnikJM, AmbrosiusWT, Effect of structured physical activity on prevention of major mobility disability in older adults: the LIFE study randomized clinical trial. JAMA 2014;311:2387–2396.10.1001/jama.2014.561624866862)| false
ThomasS, MackintoshS, HalbertJ. Does the ‘Otago exercise programme’ reduce mortality and falls in older adults? A systematic review and meta-analysis. Age Ageing 2010;39:681–687.2081793810.1093/ageing/afq102)| false
GuralnikJM, SimonsickEM, FerrucciL, et al.A short physical performance battery assessing lower extremity function: association with self-reported disability and prediction of mortality and nursing home admission. J Gerontol1994;49:M85–94.
GuralnikJM, SimonsickEM, FerrucciL, A short physical performance battery assessing lower extremity function: association with self-reported disability and prediction of mortality and nursing home admission. J Gerontol 1994;49:M85–94.10.1093/geronj/49.2.M85)| false
LevineME. Modeling the rate of senescence: can estimated biological age predict mortality more accurately than chronological age? J Gerontol A Biol Sci Med Sci 2013;68:667–674.2321303110.1093/gerona/gls233)| false
ExtermannM, BolerI, ReichRR, Predicting the risk of chemotherapy toxicity in older patients: the Chemotherapy Risk Assessment Scale for High-Age Patients (CRASH) score. Cancer 2012;118:3377–3386.10.1002/cncr.26646)| false
MufflyLS, BoulukosM, SwansonK, et al.Pilot study of comprehensive geriatric assessment (CGA) in allogeneic transplant: CGA captures a high prevalence of vulnerabilities in older transplant recipients. Biol Blood Marrow Transplant2013;19:429–434.
MufflyLS, BoulukosM, SwansonK, Pilot study of comprehensive geriatric assessment (CGA) in allogeneic transplant: CGA captures a high prevalence of vulnerabilities in older transplant recipients. Biol Blood Marrow Transplant 2013;19:429–434.10.1016/j.bbmt.2012.11.00623160006)| false
MohileSG, DaleW, SomerfieldMR, et al.Practical assessment and management of vulnerabilities in older patients receiving chemotherapy: ASCO guideline for geriatric oncology. J Clin Oncol2018;36:2326–2347.
Rodríguez-MañasL, FéartC, MannG, et al.Searching for an operational definition of frailty: a Delphi method based consensus statement: the frailty operative definition-consensus conference project. J Gerontol A Biol Sci Med Sci2013;68:62–67.
Rodríguez-MañasL, FéartC, MannG, Searching for an operational definition of frailty: a Delphi method based consensus statement: the frailty operative definition-consensus conference project. J Gerontol A Biol Sci Med Sci 2013;68:62–67.2251128910.1093/gerona/gls119)| false
WeaverKE, ForsytheLP, ReeveBB, et al.Mental and physical health-related quality of life among U.S. cancer survivors: population estimates from the 2010 National Health Interview Survey. Cancer Epidemiol Biomarkers Prev2012;21:2108–2117.
WeaverKE, ForsytheLP, ReeveBB, Mental and physical health-related quality of life among U.S. cancer survivors: population estimates from the 2010 National Health Interview Survey. Cancer Epidemiol Biomarkers Prev 2012;21:2108–2117.10.1158/1055-9965.EPI-12-074023112268)| false
RoskoAE, HuangY, BensonDM, Use of a comprehensive frailty assessment to predict morbidity in patients with multiple myeloma undergoing transplant. J Geriatr Oncol 2019;10:479–485.2998335210.1016/j.jgo.2018.05.015)| false
AlterG, RihnS, StreeckH, Ligand-independent exhaustion of killer immunoglobulin-like receptor-positive CD8+ T cells in human immunodeficiency virus type 1 infection. J Virol 2008;82:9668–9677.10.1128/JVI.00341-0818579582)| false
SinghNP, SinghUP, RouseM, et al.Dietary indoles suppress delayed-type hypersensitivity by inducing a switch from proinflammatory Th17 cells to anti-inflammatory regulatory T cells through regulation of microRNA. J Immunol2016;196:1108–1122.
SinghNP, SinghUP, RouseM, Dietary indoles suppress delayed-type hypersensitivity by inducing a switch from proinflammatory Th17 cells to anti-inflammatory regulatory T cells through regulation of microRNA. J Immunol 2016;196:1108–1122.2671294510.4049/jimmunol.1501727)| false